NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
This publication is provided for historical reference only and the information may be out of date.
Structured Abstract
Background:
Interventions to prevent smoking uptake or encourage cessation among children or adolescents may help slow or halt increased tobacco-related illness.
Purpose:
To systematically review evidence for the efficacy and harms of primary care interventions to prevent tobacco initiation and encourage tobacco cessation among children and adolescents.
Methods:
We identified three good-quality systematic reviews published since the previous USPSTF recommendation was released; two systematic reviews addressed smoking prevention that collectively covered the relevant literature through July 2002, and one Cochrane review addressed smoking cessation that included trials through August 2009. We examined the included and excluded studies of these reviews and then searched MEDLINE, PsycINFO, the Cochrane Central Register of Controlled Trials, and the Database of Abstracts of Reviews of Effects to identify literature that was published after the search dates of the three prior systematic reviews. We also examined the references from 20 other good-quality systematic reviews and other relevant publications, searched Web sites of government agencies for grey literature (February to September 2011), and monitored health news Web sites and journal tables of contents (beginning in January 2011) to identify potentially eligible trials. Two investigators independently reviewed identified abstracts and full-text articles against a set of a priori inclusion and quality criteria. Discrepancies were resolved by consensus. One investigator abstracted data into an evidence table and a second investigator checked these data. We conducted random effects meta-analyses to estimate the effect size of smoking prevention or cessation interventions on self-reported smoking status. We grouped trials based on the focus of the trial—combined prevention and cessation, prevention, or cessation.
Results:
We included 24 articles representing 19 unique studies. None of the studies examined childhood or longer-term health outcomes (e.g., respiratory health or adult smoking). Seven trials evaluating combined prevention and cessation interventions were mainly rated as fair quality and included a diverse mix of intervention components and approaches. Pooled analyses of six of the combined trials (n=8,749) resulted in a nonstatistically significant difference in the smoking prevalence among the intervention group compared with the control group at 6- to 12-months followup. Pooled analyses across all of the prevention trials suggested a small reduction in smoking initiation at 6- to 12-months followup among intervention participants compared with control group participants (risk ratio, 0.81 [95% confidence interval, 0.70 to 0.93]; k=9; n=26,624). Meta-analyses of the behavior-based cessation trials (k=7; n=2,328) and the medication (bupropion) cessation trials (k=2; n=256) did not show a statistically significant effect on self-reported smoking status among baseline smokers at 6- to 12-months followup. No trials evaluating behavior-based interventions (both prevention and cessation) reported possible harms from interventions. Some trials, however, reported a higher absolute prevalence of smoking in the intervention groups compared with the control groups, although none were statistically significant. Three studies were included that examined adverse effects related to bupropion use, and findings were mixed.
Conclusions:
Interventions designed to reduce the prevalence of tobacco use among children and adolescents represent a clinically and methodologically heterogeneous body of literature. Overall, methodological differences between the included trials limits our ability to determine if the relatively small effect found on smoking initiation in this subset of trials represents true benefit across this body of literature. In particular, the measurement of smoking status, including what constituted smoking initiation and cessation, varied across all studies. In addition, the diversity of both the components and the intensity of the interventions limit our ability to draw conclusions about common efficacious elements.
Contents
- 1. INTRODUCTION
- Scope and Purpose
- Burden of Tobacco Use
- Prevalence and Natural History of Tobacco Use
- Measurement of Tobacco Use in Children and Adolescents
- Risk Factors
- Rationale for Tobacco Use Interventions in Primary Care
- Prevention and Cessation Interventions
- Current Clinical Practice
- Recommendations of Other Groups
- Previous USPSTF Recommendation
- 2. METHODS
- 3. RESULTS
- Key Question 1 Do Interventions in Primary Care Designed to Prevent Tobacco Use or Improve Tobacco Cessation Rates in Children and Adolescents Improve Health Outcomes in Children and Adolescents and Reduce the Likelihood of Adult Smoking?
- Key Question 2 Do Interventions in Primary Care Prevent Tobacco Use in Children and Adolescents or Improve Tobacco Cessation Rates in Children and Adolescents Who Use Tobacco? What Are Elements of Efficacious Interventions? Are There Differences in Outcomes in Different Subgroups?
- Key Question 3 What Adverse Effects Are Associated With Interventions to Improve Tobacco Cessation Rates or Prevent Tobacco Use in Children and Adolescents?
- 4. DISCUSSION
- References
- Appendix A Original Search Strategies
- Appendix B Search Results and Progression of Article Inclusion
- Appendix C Excluded Studies
- Appendix D Inclusion/Exclusion Criteria
- Appendix E Comparison of Included Studies
- Appendix F U.S. Preventive Services Task Force Quality Criteria and Ratings
- Appendix G Behavioral Intervention Details
- Appendix H Trials Pending Assessment
Expert consultant: Jack Hollis, PhD
Acknowledgments: The authors acknowledge the following individuals for their contributions to this project: Therese Miller, DrPH, at the Agency for Healthcare Quality and Research; Susan J. Curry, PhD, David Grossman, MD, MPH, and J. Sanford Schwartz, MD, of the U.S. Preventive Services Task Force; Raymond S. Niaura, PhD, Steven Sussman, PhD, MA, Andrea C. Villanti, PhD, MPH, and Jonathan Winickoff, MD, MPH, who provided expert review of the report; and Kevin Lutz, MFA, Daphne Plaut, MLS, and Heather Baird at the Center for Health Research.
Prepared for: Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services1, Contract No. HHS-290-2007-10057-I, Task Order No. 13. Prepared by: Oregon Evidence-based Practice Center, Center for Health Research, Kaiser Permanente Northwest2
Suggested citation:
Patnode CD, O'Connor E, Whitlock EP, Perdue LA, Soh C. Primary Care Relevant Interventions for Tobacco Use Prevention and Cessation in Children and Adolescents: A Systematic Evidence Review for the U.S. Preventive Services Task Force. Evidence Synthesis No. 97. AHRQ Publication No. 12-05175-EF-1. Rockville, MD: Agency for Healthcare Research and Quality; December 2012.
This report is based on research conducted by the Oregon Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No. HHS-290-2007-10057-I, Task Order No. 13). The findings and conclusions in this document are those of the authors, who are responsible for its contents; the findings and conclusions do not necessarily represent the views of AHRQ. Therefore, no statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services.
The information in this report is intended to help health care decisionmakers—patients and clinicians, health system leaders, and policymakers, among others—make well-informed decisions and thereby improve the quality of health care services. This report is not intended to be a substitute for the application of clinical judgment. Anyone who makes decisions concerning the provision of clinical care should consider this report in the same way as any medical reference and in conjunction with all other pertinent information; that is, in the context of available resources and circumstances presented by individual patients.
This report may be used, in whole or in part, as the basis for the development of clinical practice guidelines and other quality enhancement tools, or as a basis for reimbursement and coverage policies. AHRQ or U.S. Department of Health and Human Services endorsement of such derivative products may not be stated or implied.
None of the investigators has any affiliations or financial involvement that conflicts with the material presented in this report.
- 1
540 Gaither Road, Rockville, MD 20850; www
.ahrq.gov - 2
3800 North Interstate Avenue, Portland, OR 97227
- Review Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: An Updated Systematic Review for the U.S. Preventive Services Task Force[ 2018]Review Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: An Updated Systematic Review for the U.S. Preventive Services Task ForceLeBlanc EL, Patnode CD, Webber EM, Redmond N, Rushkin M, O’Connor EA. 2018 Sep
- Review Behavioral Counseling and Pharmacotherapy Interventions for Tobacco Cessation in Adults, Including Pregnant Women: A Review of Reviews for the U.S. Preventive Services Task Force[ 2015]Review Behavioral Counseling and Pharmacotherapy Interventions for Tobacco Cessation in Adults, Including Pregnant Women: A Review of Reviews for the U.S. Preventive Services Task ForcePatnode CD, Henderson JT, Thompson JH, Senger CA, Fortmann SP, Whitlock EP. 2015 Sep
- Review Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Cardiovascular Disease Risk Factors: Updated Systematic Review for the U.S. Preventive Services Task Force[ 2017]Review Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Cardiovascular Disease Risk Factors: Updated Systematic Review for the U.S. Preventive Services Task ForcePatnode CD, Evans CV, Senger CA, Redmond N, Lin JS. 2017 Jul
- Review Interventions for Tobacco Cessation in Adults, Including Pregnant Women: An Evidence Update for the U.S. Preventive Services Task Force[ 2021]Review Interventions for Tobacco Cessation in Adults, Including Pregnant Women: An Evidence Update for the U.S. Preventive Services Task ForcePatnode CD, Henderson JT, Melnikow J, Coppola EL, Durbin S, Thomas R. 2021 Jan
- Review Primary care-relevant interventions for tobacco use prevention and cessation in children and adolescents: a systematic evidence review for the U.S. Preventive Services Task Force.[Ann Intern Med. 2013]Review Primary care-relevant interventions for tobacco use prevention and cessation in children and adolescents: a systematic evidence review for the U.S. Preventive Services Task Force.Patnode CD, O'Connor E, Whitlock EP, Perdue LA, Soh C, Hollis J. Ann Intern Med. 2013 Feb 19; 158(4):253-60.
- Primary Care Relevant Interventions for Tobacco Use Prevention and Cessation in ...Primary Care Relevant Interventions for Tobacco Use Prevention and Cessation in Children and Adolescents
- Taxonomy Links for Protein (Select 663530853) (1)Taxonomy
- "geo_loc_name=Mexico"[attr] (24749)BioSample
- MAG: Ignavibacteriales bacterium CG_4_9_14_3_um_filter_34_10, whole genome shotg...MAG: Ignavibacteriales bacterium CG_4_9_14_3_um_filter_34_10, whole genome shotgun sequencing projectgi|1278584842|gb|PFVB00000000.1|PFV 0000Nucleotide
- Desmin-related myofibrillar myopathyDesmin-related myofibrillar myopathyMedGen
Your browsing activity is empty.
Activity recording is turned off.
See more...